Changes in Point-of-Sale Drug Prices After Medicare Eliminated Retroactive Pharmacy Fees
This cross-sectional study evaluates associations between Medicare elimination of retroactive pharmacy fees and point-of-sale drug prices.
Authors
- Kelly E. Anderson (ORCID: https://orcid.org/0000-0002-1471-6283)
- Jason Brian Gibbons (ORCID: https://orcid.org/0000-0002-1724-6897)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Benjamin N. Rome (ORCID: https://orcid.org/0000-0001-5776-3293)
- Christopher L. Cai
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-10-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.38776
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00